Aplastic anemia (AA) is an autoimmune disorder characterized by bone marrow and
peripheral blood pancytopenia. Different environmental and genetical conditions could be …

In recent years, it has become increasingly apparent that bone marrow (BM) failures and
myeloid malignancy predisposition syndromes are characterized by a wide phenotypic …

The prevalence and functional impact of somatic mutations in nonleukemic T cells is not well
characterized, although clonal T-cell expansions are common. In immune-mediated aplastic …

Severe aplastic anemia (SAA) is a rare disorder characterized by hypoplastic bone marrow
and progressive pancytopenia. The etiology of acquired SAA is not understood but is likely …

Background Aplastic anemia (AA) is known as an autoimmune disease in which T cell
activation is aberrant. It has been reported that unconventional T cells, mucosal‐associated …

Background The immunomodulatory effects of granulocyte colony-stimulating factor (G-CSF)
on T cells result in a low incidence of acute graft-versus-host disease (aGVHD) in G-CSF …

Acquired aplastic anemia (AA) is a bone marrow failure syndrome characterized by
peripheral cytopenias and bone marrow hypoplasia. It is ultimately fatal without treatment …

Aplastic anemia (AA) is a disease characterized by bone marrow hematopoietic dysfunction
and peripheral blood pancytopenia, which is thought to be mediated by an abnormal T cell …

Objectives Aplastic anemia (AA) is T cell immune-mediated autoimmune disease. Aberrant T
cell activation involves an imbalance in T cell homeostasis in AA. However, whether the T …

Most cases of acquired aplastic anemia (AA) arise from autoimmune destruction of
hematopoietic stem and progenitor cells. Human leukocyte antigen (HLA)-haploidentical …